View printer-friendly version
« Back
January 09, 2012 10:28 a.m.
Teva to Present at the 30th Annual J.P. Morgan Healthcare Conference

JERUSALEM--(BUSINESS WIRE)--Jan. 9, 2012-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the J.P. Morgan Healthcare Conference in San Francisco, CA. Eyal Desheh, Chief Financial Officer, and William Marth, President & CEO, Teva Pharmaceuticals - Americas, will present on Tuesday, January 10, 2012.

What: Teva Presentation at the 30th Annual J.P. Morgan Healthcare Conference

Who: Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd. &

William Marth, President and CEO, Teva Pharmaceuticals - Americas

When: Tuesday, January 10, 2012 at 9:30 a.m. (PST)

Where: http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-presentations or
http://jpmorgan.metameetings.com/webcasts/healthcare12/directlink?ticker=TEVA

How: Live over the Internet - log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 47,000 people around the world and reached $16.1 billion in net sales in 2010.

Source: Teva Pharmaceutical Industries Ltd.